2021
(l-r) Stephane Bancel; Albert Bourla; Alex Gorsky; David Ricks; Pascal Soriot; George D. Yancopoulos
In recognition of the monumental feat of having developed, in less than a year, vaccines against COVID-19, as well as having developed several novel antiviral drugs that treat COVID-19 symptoms based on innovative monoclonal antibody platforms. The six companies together responded to the pandemic in record time, with safe, effective treatments that hold the promise of reducing mortality and restoring normal life for untold millions of vulnerable patients.